date:Jul 19, 2012
And did POM Wonderful cross the line with ads promoting its pomegranate juice for reducing the risk of prostate cancer and cardio disease?
Clearer answers to these questions should emerge on August 23 when five FTC Commissioners will hear oral arguments from POM and the Federal Trade Commission (FTC), which have both appealed a recent initial decision from administrative law judge Michael Chappell on a false advertising case brought by the FTC against POM in 2010.
The Commissioners will make a